Supernus Pharmaceuticals
SUPN
SUPN
243 hedge funds and large institutions have $1.37B invested in Supernus Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 87 increasing their positions, 91 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
11% less funds holding
Funds holding: 272 → 243 (-29)
20% less capital invested
Capital invested by funds: $1.71B → $1.37B (-$347M)
55% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 49
Holders
243
Holding in Top 10
1
Calls
$14.1M
Puts
$11.5M
Top Buyers
| 1 | +$18.4M | |
| 2 | +$17.9M | |
| 3 | +$17.6M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$8.9M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$8.38M |
Top Sellers
| 1 | -$67.2M | |
| 2 | -$27.1M | |
| 3 | -$26.4M | |
| 4 |
PIM
Provident Investment Management
Novi,
Michigan
|
-$24M |
| 5 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$15.5M |